by Maria Dalby: Advances in diagnostic techniques, genetic testing and immunosuppressive protocols allow clinicians to tailor interventions to the individual patient’s needs to a greater extent than in… read more.
by Bruce Sylvester: Men who have had a heart attack and then receive androgen deprivation therapy (ADT) for prostate cancer are at an increased risk of subsequent fatal… read more.
Men with asthma are less likely to have aggressive prostate cancer or to die from the disease, according to a large, prospective cohort study published in the International… read more.
Firmagon (Degarelix) is a competitive, reversible GnRH receptor blocker, for patients with advanced hormone-dependent prostate cancer. Where Injection technique is critical; Nora Sullivan, a specialist nurse at Hibernian… read more.
by Bruce Sylvester: Among patients with metastatic hormone-sensitive prostate cancer, chemotherapy with docetaxel at the start of androgen deprivation therapy (ADT) has resulted in an increased survival of… read more.
While the consequences of osteoporosis are worse in men than women – including death – older males are far less likely to take preventive measures against the potentially… read more.
by Bruce Sylvester: Women using bisphosphonates with nitrogen, which are prescribed for osteoporosis and other bone conditions, appear to have half the risk of developing endometrial cancer compared… read more.
With research and development costs for many drugs reaching well into the billions, pharmaceutical companies want more than ever to determine whether their drugs already at market have… read more.
by Thomas R. Collins – After evaluating data on 5 million adults in the UK, researchers concluded that an increasing body mass index (BMI) raises the odds of… read more.
by Bruce Sylvester – Adding goserelin to standard chemotherapy significantly reduces the risk of early menopause in breast cancer patients, researchers reported in May of 2014 at the… read more.
SAN DIEGO — Higher levels of melatonin, a hormone involved in the sleep-wake cycle, may suggest decreased risk for developing advanced prostate cancer, according to results presented here… read more.
Our defences against infection can be weaknesses in causing cancer. Scientists have discovered a genetic signature that implicates a key mechanism in the immune system as a driving… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
